Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?

about

Trigger factors of cutaneous lupus erythematosus: a review of current literature.Cutaneous side-effects of biologics in immune-mediated disorders: A histopathological perspective.Tumour necrosis factor antagonist-induced lupus: a Critically Appraised Topic.

P2860

Q38973692-B3FAC0FF-0023-4EE3-8C19-3657D59304CD Q39159787-A7FEA5A7-94A9-478D-A2CA-1F03BC5858B5 Q48298265-EEDBB83B-F616-4479-AF56-86F3E72B024F

P2860

Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?

Item

http://www.wikidata.org/entity/Q46252749

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@en

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@nl

type

Item

label

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@en

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@nl

prefLabel

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@en

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@nl

P1476

Subacute cutaneous lupus eryth ...... gonists and rituximab therapy?

@en

P2093

Eugeniusz Kucharz

http://www.w3.org/2001/XMLSchema#string

Małgorzata Widuchowska

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.

Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus--a prospective pilot study.

Drug-induced lupus: an update.

Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.

Anti-TNF-induced lupus.

P304

443-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08923973.2013.780077

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ligia Brzezińska-Wcisło

Anna Lis-Święty

P577

2013-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23537059

http://www.w3.org/2001/XMLSchema#string

P921

TNF

Subacute cutaneous lupus erythematosus

Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?

about

P2860

P2860

Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921